Investment
Features
FeesSafety
Academy
More
Pluang+

10-year Treasury yield nears 2007 peak amid Fed hikes, energy crisis, and rising US debt.

Market News
29 Sep 2026
24/7 Wall Street
View Source
Bearish
10-year Treasury yield nears 2007 peak amid Fed hikes, energy crisis, and rising US debt.

The 10-year US Treasury yield closed at 5.24% on September 28, 2026, just two basis points below its June 2007 peak of 5.26%, driven by expected Federal Reserve rate hikes, an energy crisis linked to the Iran war, ballooning US government debt, and increased AI investment. This rise is pressuring mortgage rates, which have pushed 30-year averages above 7%, and is causing stock valuations, especially growth stocks, to fall due to higher interest rates. Market watchers expect yields to climb further, potentially reaching 6%, which could deepen the impact on housing and equities. Upcoming inflation and jobs data will be key to determining the next moves, but the current environment suggests continued pressure on rate-sensitive assets.

The 10-year US Treasury yield stands at 5.24%, just two basis points shy of its 2007 peak, marking a near 20-year high amid ongoing economic pressures. For readers following US stocks on Pluang, here is the market snapshot as of Sep 29, 2026 19:33 WIB: out of 150 priced US stocks, 97 rose and 48 fell. Notable movers include HOOD at USD 118.70 (+1.92%), SPCE at USD 3.20 (+1.91%), and UAL at USD 113.50 (+1.78%), with strong buy interest reflected in Pluang order activity.

More News

CarMax Q2 earnings jump 81% as used car sales and financing income rise

CarMax Q2 earnings jump 81% as used car sales and financing income rise

CarMax reported an 81.3% increase in second-quarter diluted earnings per share to $1.16, driven by a 13.8% rise in retail used vehicle sales and a 32.1% increase in auto finance income. Despite pricing actions that lowered gross profit per vehicle by...

Company Fundamentals
Bullish
4 hours ago
Medicus Pharma files streamlined Phase 2b/3 trial for prostate cancer drug Teverelix with FDA

Medicus Pharma files streamlined Phase 2b/3 trial for prostate cancer drug Teverelix with FDA

Medicus Pharma has submitted a streamlined Phase 2b/3 trial design to the FDA for Teverelix, a long-acting GnRH antagonist targeting advanced prostate cancer patients at increased cardiovascular risk. The new trial design combines dose optimization, ...

Market News
Bullish
4 hours ago
Metallus wins $995M contract to supply steel for U.S. Defense Logistics Agency over five years.

Metallus wins $995M contract to supply steel for U.S. Defense Logistics Agency over five years.

Metallus, a specialty metals producer, secured a five-year IDIQ contract with the U.S. Defense Logistics Agency valued up to $995 million to supply steel for critical defense uses. The contract includes an initial $125 million delivery order, with Me...

Market News
Bullish
4 hours ago
Anthropic plans $2T AI IPO amid soaring revenue but massive losses raise investor caution

Anthropic plans $2T AI IPO amid soaring revenue but massive losses raise investor caution

Anthropic is preparing for an IPO with a record $2 trillion valuation, aiming to be the first pure AI company on the market. Despite a massive revenue surge of over 1,000% from 2024 to 2025, the company reported a $42 billion loss, including a $34 bi...

Market News
Neutral
4 hours ago
WTI and Brent oil prices test key support levels amid supply concerns near Strait of Hormuz.

WTI and Brent oil prices test key support levels amid supply concerns near Strait of Hormuz.

WTI crude oil prices are testing support around the 50-day EMA near $90 after falling from an initial gap up, indicating potential downward pressure if prices drop below this level. Brent crude is consolidating near its 50-day EMA around $96.40 and b...

Technical Signals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App